Droperidol
FDA-approved product (injectable, injection), marketed as Droperidol, Inapsine.
- Registered studies
- 42
- Lab records
- 0
- Pathogens at ≥40%
- 3 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Nausea and vomiting
- Post operative nausea and vomiting
- Psychosis
Indications ChEMBL records as approved, from FDA and DailyMed labels. Label ↗
- WHO therapeutic group
- Butyrophenone derivatives
- FDA pharmacologic class
- Dopamine-2 Receptor Antagonist FDA label ↗
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
This medicine is being investigated here for AI-predicted antimicrobial activity against M. tuberculosis, MRSA and E. coli. It was surfaced computationally for further investigation; it is not an established treatment for these infections.
AI-predicted activity
AI prediction · nothing measured- MRSA48.7% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- E. coli43.0% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- K. pneumoniae32.8% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis55.0% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
42registered studies name this medicine, for any condition. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredAutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Droperidol with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- DichlorphenamideExisting use: Glaucoma73.9% AI-predicted activityagainst M. tuberculosisLab records exist2 registered studies
- Tamsulosin HydrochlorideExisting use: Benign prostatic hyperplasia, Prostate carcinoma73.2% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Thiethylperazine MalateExisting use: Allergic disease71.8% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- SaquinavirExisting use: HIV infection, HIV-1 infection, Viral disease71.5% AI-predicted activityagainst M. tuberculosis50+ registered studies
- AvacopanExisting use: Anti-neutrophil antibody associated vasculitis, Anti-neutrophil cytoplasmic antibody-associated vasculitis, Granulomatosis with Polyangiitis and 1 more71.3% AI-predicted activityagainst M. tuberculosis26 registered studies
- Lasmiditan SuccinateExisting use: Migraine disorder71.0% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- SotorasibExisting use: Neoplasm, Non-small cell lung carcinoma71.0% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Vinblastine SulfateExisting use: Classic Hodgkin lymphoma, Fungal infectious disease, Hodgkins lymphoma and 3 more70.8% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Haloperidol DecanoateExisting use: Conduct disorder, Mental or behavioural disorder, Psychosis and 4 more70.1% AI-predicted activityagainst M. tuberculosis50+ registered studies
- HydrochlorothiazideExisting use: Angina pectoris, Cardiovascular disease, Chronic kidney disease and 9 more70.1% AI-predicted activityagainst M. tuberculosis50+ registered studies
- TolvaptanExisting use: Autosomal dominant polycystic kidney disease, Cardiovascular disease, Congestive heart failure and 4 more70.0% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Larotrectinib SulfateExisting use: Abdominal Neoplasms, Cancer, Metastasis and 1 more69.2% AI-predicted activityagainst M. tuberculosis5 registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Awake Nasal Intubation in Laryngopharyngeal Tumors
NCT03546088 · start 2018-02-20
Registered record
- Registry ID
- NCT03546088
- Conditions
- Airway Management
- Interventions
- fiberoptic naso-tracheal intubation; Topical anaesthesia; Light sedation
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2018-02-20
- Completion
- 2018-12-25
- Enrolment
- 32
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAirway ManagementInterventionfiberoptic naso-tracheal intubation; Topical anaesthesia; Light sedationPhaseNot applicableRegistry statusCompletedSerratus Anterior Plane Block: Post-operative Analgesia in Video-assisted Thoracic Surgery
NCT03277391 · start 2017-04-14
Registered record
- Registry ID
- NCT03277391
- Conditions
- Regional Anesthesia; Thoracic Surgery; Post-operative Pain; Post-operative Chronic Pain; Pharmacokinetic Analysis; Serratus Anterior Plane Block
- Interventions
- Serratus anterior plane block; patient-controlled analgesia
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2017-04-14
- Completion
- 2018-05
- Enrolment
- 20
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionRegional Anesthesia; Thoracic Surgery; Post-operative Pain; Post-operative Chronic Pain +2 moreInterventionSerratus anterior plane block; patient-controlled analgesiaPhaseNot applicableRegistry statusUnknownSublingual Sufentanil Tablet System (SSTS) Versus Intravenous Patient Controlled Analgesia After Back Surgery.
NCT03036514 · start 2017-04-05
Registered record
- Registry ID
- NCT03036514
- Conditions
- Pain, Postoperative
- Interventions
- Sublingual sufentanil tablet system; Patient-controlled intravenous analgesia
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2017-04-05
- Completion
- 2019-09-01
- Enrolment
- 27
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPain, PostoperativeInterventionSublingual sufentanil tablet system; Patient-controlled intravenous analgesiaPhaseNot applicableRegistry statusCompletedE7 TCR T Cells for Human Papillomavirus-Associated Cancers
NCT02858310 · start 2017-01-27
Registered record
- Registry ID
- NCT02858310
- Conditions
- Papillomavirus Infections; Cervical Intraepithelial Neoplasia; Carcinoma In Situ; Vulvar Neoplasms; Vulvar Diseases
- Interventions
- E7 TCR cells; Aldesleukin; Fludarabine; Cyclophosphamide; EKG; Biopsy; Chest CT and MRI or PET; PFT; Granisetron; Ondansetron; Droperidol; Prochlorperazine; Diphenoxylate HCL; Atropine sulfate; Codeine sulfate; Loperamide; Indomethacin; Acetaminophen; Diphenhydramine HCL; Hydroxyzine HCL; Meperidine
- Study type
- INTERVENTIONAL
- Phase
- Phase 1 / Phase 2
- Registry status
- Completed
- Start
- 2017-01-27
- Completion
- 2025-07-02
- Enrolment
- 224
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPapillomavirus Infections; Cervical Intraepithelial Neoplasia; Carcinoma In Situ; Vulvar Neoplasms +1 moreInterventionE7 TCR cells; Aldesleukin; Fludarabine; Cyclophosphamide +17 morePhasePhase 1 / Phase 2Registry statusCompletedReal-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
NCT02625181 · start 2016-07
Registered record
- Registry ID
- NCT02625181
- Conditions
- Postoperative Nausea and Vomiting
- Interventions
- Automated recommendation at the start of the case; Automated notification at the start of surgery; Preoperative recommendations: by email; Automated notification at the end of surgery; Anesthesia Information Management System (AIMS); Perioperative Data Warehouse (PDW); General anesthesia; Elective surgery; Propofol; Sevoflurane; Isoflurane; Desflurane; Scopolamine; Droperidol; Haloperidol; Dexamethasone; Promethazine; Meclizine; Aprepitant; Metoclopramide; Fentanyl; Sufentanil; Alfentanil; Remifentanil; Morphine; Meperidine; Hydromorphone; Methadone; Oxycodone; Oxymorphone; Hydrocodone; Ketamine; Ondansetron; Granisetron; Dolasetron mesylate; Palonosetron; Tropisetron; Ramosetron
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2016-07
- Completion
- 2017-11-30
- Enrolment
- 27,034
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPostoperative Nausea and VomitingInterventionAutomated recommendation at the start of the case; Automated notification at the start of surgery; Preoperative recommendations: by email; Automated notification at the end of surgery +34 morePhaseNot applicableRegistry statusCompletedA Fast-track Versus Conventional Recovery Protocol in Laparoscopic Hysterctomy
NCT03828981 · start 2016-05-31
Registered record
- Registry ID
- NCT03828981
- Conditions
- Gynecologic Surgery
- Interventions
- fast-track recovery program
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2016-05-31
- Completion
- 2018-05-30
- Enrolment
- 120
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionGynecologic SurgeryInterventionfast-track recovery programPhaseNot applicableRegistry statusCompletedProphylaxis of Postoperative Nausea and Vomiting After Cardiac Surgery
NCT02744495 · start 2016-02
Registered record
- Registry ID
- NCT02744495
- Conditions
- Postoperative Vomiting; Postoperative Nausea; Postoperative Emesis
- Interventions
- Betamethasone; Droperidol
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2016-02
- Completion
- 2016-12
- Enrolment
- 502
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPostoperative Vomiting; Postoperative Nausea; Postoperative EmesisInterventionBetamethasone; DroperidolPhasePhase 3Registry statusCompletedFamily Intervention in Recent Onset Schizophrenia Treatment (FIRST)
NCT02600741 · start 2015-07-24
Registered record
- Registry ID
- NCT02600741
- Conditions
- Schizophrenia
- Interventions
- Caregiver psycho-education and skills training; Caregiver support available at the study site; Paliperidone palmitate; Chlorpromazine; Droperidol; Fluphenazine; Haloperidol; Loxapine; Perphenazine; Pimozide; Prochlorperazine; Thiothixene; Thioridazine; Trifluoperazine; Aripiprazole; Asenapine; Clozapine; Iloperidone; Olanzapine; Paliperidone; Quetiapine; Risperidone; Ziprasidone
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2015-07-24
- Completion
- 2018-07-05
- Enrolment
- 296
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSchizophreniaInterventionCaregiver psycho-education and skills training; Caregiver support available at the study site; Paliperidone palmitate; Chlorpromazine +19 morePhaseNot recordedRegistry statusCompletedUltrasound Guided Single Shot Block of Posterior Tibial Nerve for Postoperative Pain Relief After Hallux Valgus Surgery
NCT02282956 · start 2014-10
Registered record
- Registry ID
- NCT02282956
- Conditions
- Hallux Valgus
- Interventions
- Ropivacaine 0,75%; posterior tibial nerve block; morphine and droperidol
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Unknown
- Start
- 2014-10
- Completion
- 2017-03
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHallux ValgusInterventionRopivacaine 0,75%; posterior tibial nerve block; morphine and droperidolPhasePhase 4Registry statusUnknownOptimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability
NCT02078336 · start 2013-12
Registered record
- Registry ID
- NCT02078336
- Conditions
- Dental Care for Disabled
- Interventions
- Midazolam Mylan; Lorazepam Mylan; Valium + Akineton + Dehydrobenzperidol + Atropine sulfate
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Unknown
- Start
- 2013-12
- Completion
- 2025-07
- Enrolment
- 40
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDental Care for DisabledInterventionMidazolam Mylan; Lorazepam Mylan; Valium + Akineton + Dehydrobenzperidol + Atropine sulfatePhasePhase 4Registry statusUnknownAkathisia in Post Operative Outpatients Surgery
NCT01942343 · start 2013-10
Registered record
- Registry ID
- NCT01942343
- Conditions
- Akathisia
- Interventions
- Droperidol 1,25 mg administration, Droperidol 0,625 mg administration, Odansetron 4 mg administration
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2013-10
- Completion
- 2015-10
- Enrolment
- 300
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAkathisiaInterventionDroperidol 1,25 mg administration, Droperidol 0,625 mg administration, Odansetron 4 mg administrationPhasePhase 3Registry statusCompletedClinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
NCT01765829 · start 2012-11
Registered record
- Registry ID
- NCT01765829
- Conditions
- Psychosis Nos/Other
- Interventions
- Discontinuation antipsychotic treatment; Antipsychotic treatment
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Unknown
- Start
- 2012-11
- Completion
- 2015-11
- Enrolment
- 104
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPsychosis Nos/OtherInterventionDiscontinuation antipsychotic treatment; Antipsychotic treatmentPhasePhase 3Registry statusUnknownEfficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)
NCT01594749 · start 2012-09-24
Registered record
- Registry ID
- NCT01594749
- Conditions
- Chemotherapy-Induced Nausea and Vomiting (CINV)
- Interventions
- Fosaprepitant dimeglumine; Fosaprepitant Placebo; Dexamethasone; Ondansetron; Dexamethasone Placebo; Ondansetron Placebo; Rescue Therapy
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2012-09-24
- Completion
- 2014-11-03
- Enrolment
- 1,015
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChemotherapy-Induced Nausea and Vomiting (CINV)InterventionFosaprepitant dimeglumine; Fosaprepitant Placebo; Dexamethasone; Ondansetron +3 morePhasePhase 3Registry statusCompletedStudy of Anesthesia Techniques to Reduce Nausea and Vomiting After Jaw Corrective Surgery
NCT01592708 · start 2012-06
Registered record
- Registry ID
- NCT01592708
- Conditions
- Post-operative Nausea; Post-operative Vomiting; Nausea Persistent
- Interventions
- Antiemetic anesthesia protocol
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2012-06
- Completion
- 2014-04
- Enrolment
- 233
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPost-operative Nausea; Post-operative Vomiting; Nausea PersistentInterventionAntiemetic anesthesia protocolPhaseNot applicableRegistry statusCompletedPostoperative Analgesia in Abdominal Surgery: a Medico-economic Study
NCT01470846 · start 2011-11
Registered record
- Registry ID
- NCT01470846
- Conditions
- Extended Ileal Resection Under Laparotomy; Total Proctocolectomy Under Laparotomy; Colectomy Left/Right/Total Under Laparotomy; Rectosigmoidal Resection Under Laparotomy; Anterior Resection of Rectum Under Laparotomy; Abdomino-perineal Amputation Under Laparotomy
- Interventions
- epidural analgesia; PCA
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Terminated
- Start
- 2011-11
- Completion
- 2013-04
- Enrolment
- 35
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionExtended Ileal Resection Under Laparotomy; Total Proctocolectomy Under Laparotomy; Colectomy Left/Right/Total Under Laparotomy; Rectosigmoidal Resection Under Laparotomy +2 moreInterventionepidural analgesia; PCAPhasePhase 4Registry statusTerminated